Close Menu

Keith Robison at Omics! Omics! points out a paper in PNAS in which Regeneron shows that a compound it developed called VEGF-Trap can be used to measure the amount of circulating VEGF (vascular endothelial growth factor) in blood. VEGF is a signaling molecule that stimulates angiogenesis, and is therefore used to determine dosage for drugs used to treat cancer.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Two researchers are calling for education for scientists on defending facts.

Researchers were among those who marched in London this weekend to call for another vote on Brexit.

Duke has agreed to pay $112.5 million to settle a lawsuit regarding its handling of data falsified by biologist Erin Potts-Kant. 

In PLOS this week: genetic factors influencing inorganic arsenic metabolism and toxicity, a germline variant in the cell adhesion molecule-coding gene DSCAM, and more.